Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
about
Comparative in vitro antimicrobial activities of the newly synthesized quinolone HSR-903, sitafloxacin (DU-6859a), gatifloxacin (AM-1155), and levofloxacin against Mycobacterium tuberculosis and Mycobacterium avium complexPharmacodynamics of Finafloxacin, Ciprofloxacin, and Levofloxacin in Serum and Urine against TEM- and SHV-Type Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae Isolates from Patients with Urinary Tract Infections.Pharmacodynamic modeling of the evolution of levofloxacin resistance in Staphylococcus aureusBactericidal activity and postantibiotic effect of levofloxacin against anaerobes.Efficacy of levofloxacin for experimental aortic-valve endocarditis in rabbits infected with viridans group streptococcus or Staphylococcus aureusSafety and pharmacokinetics of multiple 750-milligram doses of intravenous levofloxacin in healthy volunteers.Pharmacokinetics of levofloxacin and ciprofloxacin during continuous renal replacement therapy in critically ill patientsAntimicrobial breakpoints for gram-negative aerobic bacteria based on pharmacokinetic-pharmacodynamic models with Monte Carlo simulationAdverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.The new fluoroquinolones: A critical reviewUse of the respiratory fluoroquinolones for the outpatient management of community-acquired pneumoniaCumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapySelection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.Pharmacokinetics of Levofloxacin in Multidrug- and Extensively Drug-Resistant Tuberculosis Patients.Identifying 24 h variation in the pharmacokinetics of levofloxacin: a population pharmacokinetic approach.Population Pharmacokinetics and Pharmacodynamics of Levofloxacin in Acutely Hospitalized Older Patients with Various Degrees of Renal Function.
P2860
Q28343759-96D760F2-EDC6-42B3-8CAA-BC218077A308Q33601794-3300E5F6-7AE5-4C16-BB9C-AB2BFCEA079FQ33836597-F40F82B7-6C4C-408E-AB8A-8B9F03160DF7Q33977925-95A34195-0E8B-457A-A64B-237C54AF2EEBQ33978084-713A67D0-4F57-492B-BD09-7021C4D3A7DDQ33982566-980F3A29-59E5-48E1-AF2E-A80F83765D11Q33983228-68A7525A-94A3-4D58-AB84-8FB7656BF01CQ34188814-9BD34233-463F-4C37-89E0-10949C676319Q34551560-5AED798B-C88E-4436-9EE5-90C2CA6AD029Q35649595-F4C2BF72-4A1B-4A2B-B90A-769F9EEEE0B1Q37719126-68343B38-97FF-4C8A-8203-47B7046A25A5Q38842229-6C2539A2-2CF6-4AC7-AAF6-1D956E9CF777Q39651272-95C457C7-02C4-4C31-87C1-9872EB75B4D6Q40211670-BEA20785-A61F-480F-B39C-7C0B2572FE41Q40225657-76726F82-0F63-4ADD-BE7B-69F20489EDADQ40392507-6FC6C3FC-29DC-47EE-B27D-CBE04DE0CE35
P2860
Double-blind evaluation of the safety and pharmacokinetics of multiple oral once-daily 750-milligram and 1-gram doses of levofloxacin in healthy volunteers.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@en
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@nl
type
label
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@en
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@nl
prefLabel
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@en
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@nl
P2093
P2860
P1476
Double-blind evaluation of the ...... loxacin in healthy volunteers.
@en
P2093
C L Fowler
R R Williams
S V Callery-D'Amico
P2860
P304
P407
P577
1998-04-01T00:00:00Z